Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q2 FY25 results · Jul–Sep 2024
Max Healthcare Institute reported revenue from operations of ₹1,707.46 crore (up 25.3% from Q2 FY24) and net profit of ₹281.81 crore (up 1.9% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,707.46 | 1,363.16 | +25.3% | 1,542.95 | +10.7% |
| Other income | 40.84 | 45.48 | −10.2% | 34.68 | +17.8% |
| Total income | 1,748.30 | 1,408.64 | +24.1% | 1,577.63 | +10.8% |
| Profit before tax | 373.69 | 366.42 | +2.0% | 321.31 | +16.3% |
| Net profit for the period | 281.81 | 276.68 | +1.9% | 236.27 | +19.3% |
| EPS, basic (₹) | 2.90 | 2.85 | +1.8% | 2.43 | +19.3% |
| Net margin (%) | 16.5 | 20.3 | 15.3 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 686.11 | 596.87 | +15.0% | 621.39 | +10.4% |
| Other income | 133.51 | 48.04 | +177.9% | 42.87 | +211.4% |
| Total income | 819.62 | 644.91 | +27.1% | 664.26 | +23.4% |
| Profit before tax | 318.15 | 210.03 | +51.5% | 203.16 | +56.6% |
| Net profit for the period | 231.30 | 161.31 | +43.4% | 154.14 | +50.1% |
| EPS, basic (₹) | 2.38 | 1.66 | +43.4% | 1.59 | +49.7% |
| Net margin (%) | 33.7 | 27.0 | 24.8 |
Consolidated
- Filed with BSE
- 05 Nov 2024, 21:34 IST
- Board meeting
- 05 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Nov 2024, 21:34 IST
- Board meeting
- 05 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE